BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now
Advanced Search

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

7 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
GPR40 agonists for the treatment of type 2 diabetes mellitus: The biological characteristics and the chemical space.EBI
Shanghai University
Discovery and Optimization of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Pharmacophore- and Docking-Based Virtual Screening.EBI
Shanghai University
Design and development of a novel series of oral bivalent BET inhibitors with potent anticancer activities.EBI
Shanghai University
Biological Function of Pin1 in Vivo and Its Inhibitors for Preclinical Study: Early Development, Current Strategies, and Future Directions.EBI
Shanghai University
Discovery of a potent tyrosine kinase AXL inhibitor bearing the 3-((2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yl)amino)pyrazine core.EBI
Shanghai University
Discovery and Development of a Series of Pyrazolo[3,4-EBI
Shanghai University
Discovery of 1,8-acridinedione derivatives as novel GCN5 inhibitors via high throughput screening.EBI
Shanghai University